Decatur Capital Management, Inc. Edwards Lifesciences Corp Transaction History

Decatur Capital Management, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 13, 2019	SELL	$46.41 - $56.94 $2.74 Million - $3.36 Million	-59,050 Closed	0 $0
Q3 2018 Nov 02, 2018	SELL	$45.7 - $58.03 $670,647 - $851,590	-14,675 Reduced 19.91%	59,050 $10.3 Million
Q2 2018 Aug 01, 2018	SELL	$42.45 - $51.3 $19,102 - $23,085	-450 Reduced 0.61%	73,725 $10.7 Million
Q1 2018 May 01, 2018	SELL	$37.19 - $47.45 $81,818 - $104,390	-2,200 Reduced 2.88%	74,175 $10.3 Million
Q4 2017 Feb 06, 2018	SELL	$33.79 - $39.39 $408,859 - $476,619	-12,100 Reduced 13.68%	76,375 $8.61 Million
Q3 2017 Oct 31, 2017	BUY	$36.29 - $38.83 $3.21 Million - $3.44 Million	88,475	88,475 $9.67 Million

1,350

456M

9.76M

3.92M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $45B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Decatur Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Decatur Capital Management, Inc. with notifications on news.